Spruce Biosciences, Inc. Earnings Per Share (Basic)
Spruce Biosciences, Inc. (SPRB) reported Earnings Per Share (Basic) of -$6.68 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Spruce Biosciences, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$6.68.
- Spruce Biosciences, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$8.94.
- Spruce Biosciences, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$11.28.
- Spruce Biosciences, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$14.58.
- Spruce Biosciences, Inc. earnings per share, basic for fiscal 2025 was -$50.83.
- Spruce Biosciences, Inc. earnings per share, basic for fiscal 2024 was -$96.40.
- Spruce Biosciences, Inc. earnings per share, basic for fiscal 2023 was -$1.24.
- Spruce Biosciences, Inc. earnings per share, basic for fiscal 2022 was -$1.96.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$6.68 10-Q · filed 2026-08-12 | -$14.96 10-Q · filed 2026-08-12 | -$25.37 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$36.27 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2026-03-31 | -$8.94 10-Q · filed 2026-05-13 | -$20.16 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$32.59 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$38.90 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-12-31 | -$11.28 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$24.57 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$30.50 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$50.83 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$14.58 10-Q · filed 2025-11-10 | -$17.81 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$41.25 10-Q · filed 2025-11-10 | -$83.50 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-06-30 | -$3.50 10-Q · filed 2026-08-12 | -$27.36 10-Q · filed 2026-08-12 | -$68.77 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$84.76 derived: net income ÷ weighted average shares · filed 2026-08-12 | ||||
| 2025-03-31 | -$23.95 10-Q · filed 2026-05-13 | -$0.32 10-Q · filed 2025-05-06 | -$66.00 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$82.14 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$99.07 derived: net income ÷ weighted average shares · filed 2026-05-13 | |||
| 2024-12-31 | -$42.58 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$58.39 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$75.17 derived: net income ÷ weighted average shares · filed 2026-04-09 | -$96.40 10-K · filed 2026-03-09 | -$1.29 10-K · filed 2025-04-15 | |||
| 2024-09-30 | -$15.75 10-Q · filed 2025-11-10 | -$0.21 10-Q · filed 2024-11-12 | -$32.47 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$53.68 10-Q · filed 2025-11-10 | -$0.72 10-Q · filed 2024-11-12 | -$1.90 derived: net income ÷ weighted average shares · filed 2025-11-10 | ||
| 2024-06-30 | -$16.73 10-Q · filed 2025-08-14 | -$0.22 10-Q · filed 2024-08-12 | -$37.94 10-Q · filed 2025-08-14 | -$0.51 10-Q · filed 2024-08-12 | -$1.12 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$1.40 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$0.28 10-Q · filed 2025-05-06 | -$0.53 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.15 derived: net income ÷ weighted average shares · filed 2025-05-06 | ||||
| 2023-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.55 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$0.86 derived: net income ÷ weighted average shares · filed 2025-04-15 | -$1.24 10-K · filed 2025-04-15 | ||||
| 2023-09-30 | -$0.30 10-Q · filed 2024-11-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$1.01 10-Q · filed 2024-11-12 | -$1.44 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||||
| 2023-06-30 | -$0.32 10-Q · filed 2024-08-12 | -$0.71 10-Q · filed 2024-08-12 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$1.61 derived: net income ÷ weighted average shares · filed 2024-08-12 | ||||
| 2023-03-31 | -$0.40 10-Q · filed 2024-05-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$1.34 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$1.84 derived: net income ÷ weighted average shares · filed 2024-05-13 | ||||
| 2022-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$0.96 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$1.46 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$1.96 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | -$0.48 10-Q · filed 2023-11-13 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$1.49 10-Q · filed 2023-11-13 | -$1.88 derived: net income ÷ weighted average shares · filed 2023-11-13 | ||||
| 2022-06-30 | -$0.51 10-Q · filed 2023-08-14 | -$1.01 10-Q · filed 2023-08-14 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||||
| 2022-03-31 | -$0.50 10-Q · filed 2023-05-15 | -$0.89 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-05-15 | |||||
| 2021-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.88 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.81 10-K · filed 2023-03-16 | |||||
| 2021-09-30 | -$0.49 10-Q · filed 2022-11-10 | -$1.42 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |